Mamdani's campaign emphasized rent freezes, free buses, and expanded child care services in a message that resonated with ...
Q3 2025 Earnings Call Transcript November 4, 2025 Verastem, Inc. misses on earnings expectations. Reported EPS is $-1.35 EPS, expectations were $-0.51. Operator: Good morning, and welcome to Verastem ...
Q3 2025 Earnings Call November 5, 2025 9:00 AM ESTCompany ParticipantsRandall Giveans - Executive Vice President of ...
Q3 2025 Earnings Call Transcript November 4, 2025 Amicus Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...
His election signals a seismic shift in city politics, blending economic populism with a foreign-policy edge that could reshape the Democratic Party’s future. Zohran Mamdani, a ...
Freshworks Inc. (Nasdaq: FRSH), the leading provider of uncomplicated software that delivers exceptional customer and employee experiences, today announced financial results for its third quarter ...
Promarkerendo Test For Endometriosis Receives $0.5M Grant. Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, announced it has been awarded a $500 ...
The fact that a former CIA officer and Navy veteran shellacked their Republican opponents in statewide elections Tuesday offers a reminder that national security bona fides are still very marketable ...
Initiated PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to standard of care in participants with cystic fibrosis ...
GoodRx Holdings, Inc. ( GDRX) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx Third Quarter 2025 Earnings Call. As a ...
U.S. President Donald Trump welcomes Japanese Prime Minister Takaichi Sanae to deliver remarks to Yokosuka Naval troops aboard the USS George Washington at Yokosuka Naval Base, Japan on Oct. 28, 2025.
ORX750: Demonstrated potential best-in-class profile for treatment of narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic ...